Scott M. Dehm

10.0k total citations · 2 hit papers
116 papers, 5.2k citations indexed

About

Scott M. Dehm is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Scott M. Dehm has authored 116 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pulmonary and Respiratory Medicine, 57 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in Scott M. Dehm's work include Prostate Cancer Treatment and Research (91 papers), Ubiquitin and proteasome pathways (23 papers) and Hormonal and reproductive studies (19 papers). Scott M. Dehm is often cited by papers focused on Prostate Cancer Treatment and Research (91 papers), Ubiquitin and proteasome pathways (23 papers) and Hormonal and reproductive studies (19 papers). Scott M. Dehm collaborates with scholars based in United States, Canada and United Kingdom. Scott M. Dehm's co-authors include Donald J. Tindall, Yingming Li, Siu Chiu Chan, Lucy J. Schmidt, Hannelore V. Heemers, Robert L. Vessella, Kevin A.T. Silverstein, Keith Bonham, Tae Hyun Hwang and Lucas J. Brand and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Scott M. Dehm

105 papers receiving 5.2k citations

Hit Papers

Splicing of a Novel Androgen Receptor Exon Generates a Co... 2008 2026 2014 2020 2008 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott M. Dehm United States 37 3.7k 2.7k 1.5k 1.1k 1.1k 116 5.2k
Vivek Arora United States 21 3.3k 0.9× 2.0k 0.7× 1.3k 0.9× 803 0.7× 812 0.8× 38 4.8k
Philip A. Watson United States 17 3.1k 0.8× 1.8k 0.7× 1.2k 0.8× 805 0.7× 760 0.7× 25 4.3k
John Wongvipat United States 23 5.1k 1.4× 3.3k 1.2× 2.0k 1.3× 1.1k 1.0× 1.2k 1.1× 35 7.4k
Marcus V. Cronauer Germany 32 2.3k 0.6× 1.7k 0.6× 779 0.5× 957 0.9× 745 0.7× 73 3.8k
Changmeng Cai United States 29 2.2k 0.6× 1.8k 0.7× 964 0.7× 600 0.5× 589 0.6× 55 3.3k
Hannelore V. Heemers United States 23 1.8k 0.5× 1.7k 0.6× 1.2k 0.8× 572 0.5× 647 0.6× 45 3.2k
Michael C. Haffner United States 34 2.5k 0.7× 2.8k 1.0× 1.5k 1.0× 310 0.3× 369 0.3× 120 5.3k
Lucy J. Schmidt United States 24 1.5k 0.4× 1.6k 0.6× 608 0.4× 500 0.4× 629 0.6× 32 2.7k
Joshi J. Alumkal United States 31 2.8k 0.8× 1.8k 0.6× 1.3k 0.8× 425 0.4× 342 0.3× 136 4.7k
Ricardo M. Attar United States 30 827 0.2× 1.7k 0.6× 652 0.4× 864 0.8× 485 0.5× 72 3.2k

Countries citing papers authored by Scott M. Dehm

Since Specialization
Citations

This map shows the geographic impact of Scott M. Dehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Dehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Dehm more than expected).

Fields of papers citing papers by Scott M. Dehm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Dehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Dehm. The network helps show where Scott M. Dehm may publish in the future.

Co-authorship network of co-authors of Scott M. Dehm

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Dehm. A scholar is included among the top collaborators of Scott M. Dehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Dehm. Scott M. Dehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Døhlen, Gaute, Megan Ludwig, Hai Dang Nguyen, et al.. (2025). Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer. Oncotarget. 16(1). 606–620.
2.
Νικολακόπουλος, Αθανάσιος Ν., et al.. (2024). Evolving copy number gains promote tumor expansion and bolster mutational diversification. Nature Communications. 15(1). 2025–2025. 5 indexed citations
5.
McCluskey, Braedan M., Scott Johnson, Kenneth Jacobsohn, et al.. (2024). Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling. Science Advances. 10(9). eadi2742–eadi2742. 4 indexed citations
6.
Lee, Adam M., Yingbo Huang, Yeung Ho, et al.. (2023). Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling. Proceedings of the National Academy of Sciences. 120(17). e2218522120–e2218522120. 11 indexed citations
7.
Sicotte, Hugues, Krishna R. Kalari, Sisi Qin, et al.. (2022). Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment. Molecular Cancer Research. 20(12). 1739–1750. 9 indexed citations
8.
Li, Yingming, Rendong Yang, Christine Henzler, et al.. (2020). Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer. Clinical Cancer Research. 26(8). 1965–1976. 62 indexed citations
9.
Lee, John K., Yingming Li, Donald J. Vander Griend, et al.. (2019). PEG10 Promoter–Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer. Cancer Research. 79(21). 5668–5680. 12 indexed citations
10.
Glumac, Paige M., Yingming Li, Paari Murugan, et al.. (2019). Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer. Clinical Cancer Research. 26(5). 1054–1064. 17 indexed citations
11.
Dalal, Kush, Meixia Che, Aishwariya Sharma, et al.. (2017). Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions. Molecular Cancer Therapeutics. 16(10). 2281–2291. 27 indexed citations
12.
Etten, Jamie L. Van, Michael D. Nyquist, Yingming Li, et al.. (2017). Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer. Cancer Research. 77(19). 5228–5235. 51 indexed citations
13.
Sperger, Jamie M., Allison W. Welsh, Benjamin P. Casavant, et al.. (2016). Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation. Clinical Cancer Research. 23(3). 746–756. 50 indexed citations
14.
Li, Yingming, Siu Chiu Chan, Lucas J. Brand, et al.. (2012). Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines. Cancer Research. 73(2). 483–489. 526 indexed citations breakdown →
15.
Li, Yingming, et al.. (2011). Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression. Cancer Research. 71(6). 2108–2117. 160 indexed citations
16.
Shin, Sook, Tae‐Dong Kim, Fang Jin, et al.. (2009). Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81. Cancer Research. 69(20). 8102–8110. 67 indexed citations
17.
Dehm, Scott M., Lucy J. Schmidt, Hannelore V. Heemers, Robert L. Vessella, & Donald J. Tindall. (2008). Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance. Cancer Research. 68(13). 5469–5477. 637 indexed citations breakdown →
18.
Dehm, Scott M., Kevin M. Regan, Lucy J. Schmidt, & Donald J. Tindall. (2007). Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion–Independent Prostate Cancer Cells. Cancer Research. 67(20). 10067–10077. 64 indexed citations
19.
Heemers, Hannelore V., Kevin M. Regan, Scott M. Dehm, & Donald J. Tindall. (2007). Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer. Cancer Research. 67(21). 10592–10599. 53 indexed citations
20.
Debes, José D., Barbara Comuzzi, Lucy J. Schmidt, et al.. (2005). p300 Regulates Androgen Receptor–Independent Expression of Prostate-Specific Antigen in Prostate Cancer Cells Treated Chronically with Interleukin-6. Cancer Research. 65(13). 5965–5973. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026